MedicalResearch.com Interview with: Lilian Abbo, M.D. Associate Professor of Clinical Medicine Division of Infectious Diseases University of Miami Miller School of Medicine Medical Director...
MedicalResearch.com eInterview with:
Fengcai Zhu
Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, Jiangsu provincial center for disease prevention and control
MedicalResearch.com Editor's Note: HFMD = Hand Foot and Mouth Disease
MedicalResearch.com: What are the main findings of the study? Answer: From this trial, the inactivated alum-adjuvant EV71 vaccine showed a good protection for both the EV71-associated HFMD and EV71-associated disease. The vaccine gave 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease (including neurological complications) for at least 12 months. The safety profile and immunogenicity of this vaccine is proved to be clinical acceptable. We also proposed a titre (1:32) of neutralization antibody as surrogate of protection against EV71-associated disease.MedicalResearch.com eInterview with Muhammad Mamdani Director, Applied Health Research Centre, St. Michael's Hospital Scientist in the Keenan Research Centre of the Li...
MedicalResearch.com eInterview with Luis Beck-da-Silva, MD, ScD Cardiology Division, Heart Failure Clinic Hospital de Clínicas de Porto Alegre Rua Ramiro Barcelos, 2350 Sala...
Manuel Franco MD, PhD Associate Professor Department of Health Sciences, Public Health Unit Universidad de Alcalá Johns Hopkins Bloomberg School of Public Health Adjunct Associate Professor Dept. of Epidemiology [email protected]
MedicalResearch.com: What are the main findings of the study? Dr. Franco: Population wide weight loss of about 5 kg was related with large decreases in diabetes and cardiovascular mortality. On the contrary, Body weight regain was related with an increase in diabetes prevalence, incidence, and mortality, as well as a deceleration in the previously declining rates of cardiovascular death. (more…)